Bliss is a mental-health technology company originally founded in Albania and now headquartered in Finland. Its platform pairs licensed therapists operating in more than ten countries with AI systems that perform cultural and linguistic matching so patients can receive care from professionals who understand their specific context. Unlike many AI therapy chatbots, Bliss positions its technology as a clinician-supervised layer: therapist-trained digital companions replicate each clinician’s style, tone, and treatment approach to extend care between sessions. The company targets diaspora populations and enterprises with globally distributed workforces, where cultural nuance is critical to effective therapy. Near-term plans include launching the first cohort of therapist-trained AI companions, expanding into large diaspora markets such as the United States, and scaling partnerships with multinational employers. Bliss also intends to deepen its AI governance and clinical-oversight frameworks to maintain safety and regulatory compliance. The startup’s recent $270,000 infusion marks its first external capital, and no revenue or user metrics have yet been disclosed.

Total raised

$0M

Funding rounds

1

Latest round

Equity

Latest activity

Mar 2026